# GATE_Q_REPORT_BIM-002-CYBER-PHARMA_PASS.md

**Project:** Cyber Pharma v1 — Phase 3
**Module:** BIM-002-CYBER-PHARMA — Row-Level Security
**Gate:** Gate Q
**QA Lead:** Sol
**Director:** Tony
**Certification SHA:** `dfc8a6a4644081bef5a5142c27f2c77e4a6be3d9`
**PRE-Q attacked specimen:** `53f1ac0004f40e4df9e403188382b16afb92899f`
**Date:** 2026-09-02

## VERDICT

# PASS

BIM-002-CYBER-PHARMA is independently QA-certified.

PRE-Q established:

* **Implementation defects: ZERO**
* **Engineering rework: ZERO**
* Cross-tenant isolation held under independent attack.
* Four-helper authorization boundary held.
* Formulation C reproduced correctly.
* Helper ownership, security mode and ACL boundary held.
* Deny-all tables remained deny-all.
* Storage scope remained untouched.
* Forbidden membership sources were absent from BIM-002 authorization logic.
* Mutation denials were independently ground-truthed.
* Same-session membership revocation was proven on One-Walk attempt 3 with the same client, exact identity, byte-identical token and no `TOKEN_REFRESHED` event.
* REPLICA reproduced SCRATCH with zero observed security-significant differences.

The ratified AC3(b) finding, E-6, was a specification wording defect only. Implementation stood unchanged.

F-14 correctly records the resulting QA law that denial shape must be asserted per case rather than classifying arbitrary errors as DENY.

## Final-SHA Integrity

Certification support independently confirmed:

* active branch: `main`
* HEAD: `dfc8a6a4644081bef5a5142c27f2c77e4a6be3d9`
* protected implementation diff between PRE-Q specimen and certification SHA: **EMPTY**

Protected paths:

* `supabase/migrations/`
* `scripts/rls-harness/`
* `scripts/db-reset.mjs`
* `src/`
* `package.json`

Therefore the implementation certified here is the same implementation independently attacked during PRE-Q.

**No database replay is required.**

## Documentation Discrepancies

Three non-blocking documentation discrepancies remain:

* E-2 heading contains stale pending-ratification wording.
* E-4 status text does not record its completed ratification.
* `RECOVERY.md` reflects the pre-merge/pre-certification state.

These do not affect the validity of the implementation, PRE-Q evidence, final-SHA integrity, or this Gate Q verdict.

They may be corrected in the final **documentation-only closure commit** without reopening QA.

## Branch-Recovery Incident

During PRE-Q closeout, Architect/Engineering bookkeeping was accidentally initiated while the Director remained on disposable branch `qa/bim002`.

The mistake was detected before commit.

The QA package was banked, the disposable branch cleaned, the Director returned to the official module branch, approved QA artifacts were copied over, the implementation fence was reverified, and the closeout material was committed through the branch of record.

The disposable QA branch was **not merged**.

Classification:

**Process defect only. No implementation or QA-evidence integrity defect.**

New Factory doctrine:

> QA finishes on the disposable branch; Architect/Engineering closeout begins only after the Director has exported the permanent QA package and returned to the official module branch.

## FINAL GATE Q STATUS

**PASS — BIM-002-CYBER-PHARMA MAY CLOSE.**
